← Open Payments lookup

OLAMIDE VINCENT: Open Payments

NPI 1013474238 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,369 in 23 payments from 10 companies in 2025. Trend: 2023 $1,115 · 2024 $1,046 · 2025 $2,369

Food & beverage: $2,369
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.7$524
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$459
Teva Pharmaceuticals USA, Inc.3$282
Axsome Therapeutics, Inc.2$244
E.R. Squibb & Sons, L.L.C.2$207
Janssen Pharmaceuticals, Inc1$150
Neurocrine BioSciences, Inc.1$131
Otsuka America Pharmaceutical, Inc.1$125
ABBVIE INC.1$125
Alkermes, Inc.1$122

Products named: FANAPT, CAPLYTA, AUSTEDO XR, Auvelity, COBENFY, SPRAVATO, INGREZZA, ABILIFY MAINTENA.

Industry payments across DE — which companies pay providers there.